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Abstract:  As an intracellular protozoan parasite, Toxoplasma gondii is likely to exploit proteases for host 
cell invasion, acquisition of nutrients, avoidance of host protective responses, escape from the 
parasitophorous vacuole, differentiation, and other activities. T. gondii serine protease inhibitor 1 (TgPI1) 
is the most abundantly expressed protease inhibitor in parasite tachyzoites. We show here that alternative 
splicing produces two TgPI1 isoforms, both of which are secreted via dense granules into the 
parasitophorous vacuole shortly after invasion, become progressively more abundant over the course of 
the infectious cycle, and can be detected in the infected host cell cytoplasm. To investigate TgPI1 
function, the endogenous genomic locus was disrupted in the RH strain background. ΔTgPI1 parasites 
replicate normally as tachyzoites but exhibit increased bradyzoite gene transcription and labeling of 
vacuoles with Dolichos biflorus lectin under conditions promoting in vitro differentiation. The 
differentiation phenotype can be partially complemented by either TgPI1 isoform. Mice infected with the 
ΔTgPI1 mutant display ∼3-fold-increased parasite burden in the spleen and liver, and this in vivo 
phenotype is also complemented by either TgPI1 isoform. These results demonstrate that TgPI1 
influences both parasite virulence and bradyzoite differentiation, presumably by inhibiting parasite and/or 
host serine proteases. 
 
Introduction 
Parasitic life history strategies might be expected to balance host-pathogen interactions so that 
the competition between virulence factors and immune responses produces an equilibrium 
ensuring the survival of both the parasites and their hosts (2). Proteases have been shown to play 
an important role in pathogenesis in many viral, bacterial, and parasitic systems (20, 24, 33), and 
the regulation of protease activity is likely to be a critical aspect of pathogen biology (1). Serine 
protease inhibitors are commonly grouped into categories based on their primary sequences, 
structural motifs, and mechanisms of binding (28), and the Kazal, Kunitz, Serpin, and Smapin 
(small serine protein inhibitor) families have all been implicated in pathogen survival (21, 31, 32, 
49, 51, 55, 56).  
Protease inhibitors have been extensively characterized in metazoa but are absent from most of 
the protozoan taxa for which complete genomes are available (10). However, putative Kazal-type 
inhibitors have been identified in a subclass of apicomplexan parasites termed the Coccidia 
including Cryptosporidium (four genes), Neospora (at least two), and Toxoplasma (six); 
noncoccidial apicomplexan parasites (Plasmodium, Babesia, Theileria, etc.) show no evidence of 
any serine protease inhibitors. While the functions of coccidial Kazal-type protease inhibitors are 
not known, they have been hypothesized to protect parasites from proteolytic damage in the gut, 
suppress proteolytic activity during parasite replication, and counteract host proteases of the 
innate immune system (8, 39, 40, 44). Kazal-type protease inhibitors consist of one or more 
domains, each containing six conserved cysteines that form three intradomain disulfide bonds. 
Each domain displays an accessible surface loop containing a peptide bond called the reactive 
site, which specifically interacts with the active site of the target protease (44). All coccidian 
Kazal-type inhibitors appear to be “nonclassical” based on the short spacing between cysteines 1 
and 2, a property that is thought to impart greater specificity for the target protease (22).  
Biochemical studies have shown that Toxoplasma gondii serine protease inhibitor 1 (TgPI1) 
inhibits a broad range of serine proteases (40), while TgPI2 inhibits trypsin (39) and Neospora 
caninum PIS (NcPIS) inhibits subtilisin (8, 41). All appear to traffic via the default “dense-
granule” secretory pathway into the parasitophorous vacuole (PV), within which these obligate 
intracellular parasites replicate (26). Apicomplexan Kazal-type inhibitors could potentially target 
either parasite or host proteases, but their physiologically relevant targets remain unknown. To 
investigate the functions of these inhibitors, we genetically deleted TgPI1, the dominant Kazal 
inhibitor in T. gondii (expressed at least 10-fold more highly than TgPI2), which is present as 
two isoforms during all major stages of the parasite life cycle (tachyzoites, bradyzoites, and 
sporozoites). ΔTgPI1 mutants exhibit altered differentiation and in vivo growth phenotypes that 
can be complemented by either TgPI1 isoform.  
Materials and Methods 
Parasite and cell culture. All parasite strains were propagated as tachyzoites in human foreskin 
fibroblasts (HFF), as previously described (47). Wild-type RH, Prugniaud, and VEG strains were used as 
representatives of the type I, II, and III lineages defined by population genetic studies (23). Mutant 
parasites were constructed in the RHΔHXGPRT knockout background (16). 
Western blotting, metabolic labeling, and immunoprecipitation. Parasites were harvested 
from infected HFF (in T25 flasks) by scraping and passage through a blunt 27-gauge needle, and 
the centrifuged pellets were resuspended in pH 7.6 phosphate-buffered saline (PBS) containing 5 
mM MgCl2, 0.5% Triton X-100, 100 U/ml DNase, and protease inhibitors (Sigma P8340). 
Proteins (∼106 tachyzoite equivalents per lane) were analyzed by SDS-PAGE on Novex bis-tris 
4 to 12% gradient gels (Invitrogen) in parallel with prestained standards. After electrotransfer to 
nitrocellulose, the membranes were blocked in PBS containing 5% nonfat dry milk and 0.05% 
Tween 20 prior to adding rabbit anti-TgPI1 (1:5,000) (44). After washing, the membranes were 
incubated with peroxidase-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch) and 
visualized by chemiluminescence (GE Healthcare).  
For metabolic labeling, confluent HFF monolayers in T175 flasks were infected with ∼4 × 107 
tachyzoites 20 h before labeling for 15 min with [35S]methionine/cysteine (50 mCi/ml). After 
washing, the cultures were chased for 0, 10, 25, or 60 min in unlabeled medium; harvested by 
scraping and centrifugation; passed 3 times through a 25-gauge needle; and solubilized in 1 ml 
RIPA buffer (50 mM Tris-HCl, pH 7.5, 1% Triton X-100, 0.5% sodium deoxycholate, 0.2% 
sodium dodecyl sulfate, 100 mM NaCl, 5 mM EDTA) containing 10 mg/ml RNase A, 20 mg/ml 
DNase I, and protease inhibitors. Samples were preincubated overnight at 4°C with protein G-
Sepharose alone and centrifuged, and the supernatants were incubated for 1 h in rabbit anti-
TgPI1 antiserum, followed by the addition of protein G-Sepharose and further incubation for 1 h. 
The precipitated complexes were washed 4 times, boiled in electrophoresis buffer containing 
10% SDS and 2% β-mercaptoethanol, separated by polyacrylamide gel electrophoresis, 
incubated in Amplify fluorographic enhancer (Amersham), dried on cellophane, and exposed to 
X-ray film.  
MALDI mass spectrometry. Matrix-assisted laser desorption ionization—time of flight mass 
spectrometry (MALDI-TOF MS) was performed on a Voyager DE-STR (PerSeptive Biosystem) 
equipped with a 337-nm nitrogen laser. Unless otherwise specified, spectra were obtained in 
positive acquisition mode, and external peptides were used for calibration; the reported peptide 
masses are monoisotopic, while intact protein masses are average masses.  
Parasites were cultivated in five T175 flasks until complete lysis of the host cell monolayer 
occurred, centrifuged, and passed through a 0.45-μm filter, and the filtrate (containing secreted 
TgPI1) was incubated overnight with protein A-agarose beads (Bio-Rad) coupled to polyclonal 
rabbit anti-TgPI1. After extensive washing with Tris, pH 8.0, bound protein was eluted in 100 
mM glycine, pH 3.0, and protein-containing fractions (Bradford assay) were pooled and 
concentrated in a Centricon filter (Millipore). After electrophoresis on polyacrylamide gels and 
staining with copper, intact proteins were excised and extracted using standard methods (11): 
bands were sequentially incubated in 50 mM NH4HCO3 (10 min), followed by 50% acetonitrile, 
200 mM NH4HCO3 (30 min, twice), and then high-performance liquid chromatography (HPLC) 
grade water; crushed with a pointed dental tool; covered with 20 μl of 10 mg/ml sinapinic acid 
(matrix) in 0.5% trifluoroacetic acid (TFA) in acetonitrile; and extracted by vortexing for 3 h at 
room temperature. Following extraction, the tubes were opened to evaporate the contents for 
∼20 min with vortexing until the matrix solution became slightly cloudy, and 1 μl supernatant 
was deposited onto the MALDI probe. After calibration with aldolase, spectra were acquired in 
linear mode (acceleration, 25 keV; 91% grid voltage; 1,000-ns delay; 100 laser shots per 
spectrum), yielding an error of <10 atomic mass units. Peak masses were assigned based on the 
centroid at 50% height, and standard deviations were calculated based on at least three 
independent spectra per protein.  
For peptide analysis, bands were excised, reduced by 1 h of incubation at 56°C in 50 mM 
dithiothreitol (in 100 mM NH4CO3), and alkylated by treatment for 45 min with 275 mM 
iodoacetamide (in 100 mM NH4CO3) in the dark. After in-gel digestion with 12.5 ng/μl trypsin 
in 50 mM NH4HCO3 and solvent extraction (50), the peptide mixtures were dried, dissolved in 2 
μl 50% acetonitrile plus 0.3% TFA, mixed with saturated CHCA (α-cyano-4-hydroxycinnamic 
acid) matrix, and deposited on the MALDI MS target plate. Spectra were acquired in reflection 
mode with delayed extraction. Peptide mass fingerprints were used to search against the NCBI 
nonredundant database using MS-Fit (http://prospector.ucsf.edu) or FindPept 
(http://web.expasy.org/findpept/), based on a threshold mass deviation of 50 ppm.  
Molecular genetic manipulations. Total parasite RNA was isolated from freshly harvested 
tachyzoites (RNAEasy; Qiagen), and 2 μg purified RNA was subjected to reverse transcription 
(RT)-PCR (60 min of reverse transcription at 42°C using Moloney murine leukemia virus 
reverse transcriptase [Promega]) amplification using Expand High Fidelity PCR (Roche) and 
primers 5′-GATCGGATCCGCTTCGCCCGAAACGAAA-3′ (forward; BamHI site is underlined) 
and 5′-GATCGGTACCTTGGTCATCCCAGATCTCTTCG-3′ (reverse; KpnI site is underlined). 
PCR product sizes were analyzed by gel electrophoresis, and the products were sequenced.  
The TgPI1 targeting construct was engineered by PCR amplifying 3.6 kb of TgPI1 3′ flanking 
sequence with primers 5′-GATCGGATCCCAAAGGCATCTTTGCTTG-3′ (forward; BamHI site 
is underlined) and 5′-GATCGAGCTCTTTGCGTAAGTCTTGCCGTTG-3′ (reverse; SacI site is 
underlined) and cloning it downstream of the dhfrHXGPRTdhfr selectable marker (12). 5′ TgPI1 
sequence (2.5 kb) was amplified using primers 5′-
GATGGTGTAGTGGTATCACGCCTGATTTGC-3′ (forward) and 5′-
AGATCTGGGCCCATAAGCTTTTTACGACGGGTTAGCAC-3′ (reverse; underlined sequence 
indicates a link added to facilitate further fusion PCR) and joined to the dhfrHXGPRTdhfr 
cassette plus 3′ TgPI1 sequences amplified using primers 5′-AGCTTATGGGCCCAGATCTA-3′ 
(forward; link sequence is underlined) and 5′-CACTCTAACGCGTTCACCCTAAATGGCC-3′ 
(reverse) by fusion PCR using the 5′ flanking region forward primer and dhfrHXGPRTdhfr plus 
3′ flanking sequence reverse primer (underlined sequences indicate complementary nucleotides). 
RHΔHXGPRT strain parasite tachyzoites (107) (16) were directly transfected with 30 μg of the 
8.1-kb fusion PCR product and selected in 25 μg/ml mycophenolic acid plus 50 μg/ml xanthine 
as previously described (16).  
Surviving populations were screened for (i) loss of the TgPI1 locus using primers 5′-
GATCGGATCCCCCGTCGTAAAAATGGGAAAGAATCC-3′ (P1) (forward; BamHI site is 
underlined) and 5′-GATCCCTAGGTTGGTCATCCCAGATCTCTTCGG-3′ (P2) (reverse; AvrII 
site is underlined), (ii) presence of the HXGPRT selectable marker using primers 5′-
GTCGGTTGACAAGTGTTCTGGCAGGC-3′ (P3) and 5′-
CACTCTAACGCGTTCACCCTAAATGGCC-3′ (P4), and (iii) homologous recombination of 
HXGPRT into the TgPI1 locus using primers P3 and 5′-
CTAGATGCAGTCTGCGGAGATAGCTCAT-3′ (P5). Positive populations were cloned by 
serial dilution in 96-well plates, and the isolated clones were screened using the same primers.  
Fluorescent fusion proteins (for subcellular localization) and glutathione S-transferase (GST) 
fusion proteins (for functional complementation and purification) were engineered by amplifying 
TgPI1α or TgPI1β coding sequences using primers 5′-
GATCGGATCCCCCGTCGTAAAAATGGGAAAGAATCC-3′ (forward) and 5′-
GATCCCTAGGTTGGTCATCCCAGATCTCTTCGG-3′ (reverse) and cloning into plasmid 
tubmRFP, tubYFP, or tubGST (42), all of which harbor a sagCATsag cassette; selected in 20 
μM chloramphenicol; and cloned by limiting dilution.  
For genomic hybridization, 5 μg DNA from parental RHΔHXGPRT parasites, TgPI1 knockout 
mutants, and complemented clones was digested with EcoRI, separated on a 0.7% agarose gel, 
transferred to a Hybond N+ membrane (Amersham), and hybridized with digoxigenin probes 
(Roche) generated by PCR amplification of coding sequence primers 5′-
CGCAGCAGGATGACGAATCTGA-3′ (forward) and P2 (see above) or 5′ flanking region 
primers 5′-CTCCTGTACCCTTTCGACTTCGTC-3′ (forward) and 5′-
CGTTCCAGTTGTTCGTGCGGTGAAT-3′ (reverse).  
For expression profiling, confluent monolayers of HFF grown in T25 flasks containing 
Dulbecco's modified Eagle medium supplemented with 20% medium 199 (Life Technologies) 
and 10% cosmic calf serum (HyClone) were inoculated with 5 × 105 RHΔHXGPRT or ΔTgPI1 
tachyzoites, and RNA was extracted after 36 h (RNeasy kit; Qiagen). The RNA was labeled 
using Ovation Amp v2 (NuGen) according to the manufacturer's instructions and hybridized to a 
custom T. gondii Affymetrix array (3). Gene expression levels were determined using robust 
multichip average (RMA) normalization.  
Fluorescence microscopy. HFF grown on glass coverslips and infected with parasites were 
fixed for 20 min in 4% paraformaldehyde plus 0.02% glutaraldehyde, permeabilized for 15 min 
in 0.2% Triton X-100, washed several times in PBS, blocked for 30 to 60 min in 5% fetal bovine 
serum plus 3% bovine serum albumin (fraction V; Sigma), and incubated for 1 h with primary 
antibody (see above), followed by 1 h of incubation with Alexa 594- or Alexa 488-conjugated 
goat anti-mouse or goat anti-rabbit antiserum (Molecular Probes). The slides were mounted in 
Fluormount G (Southern Biotechnology) and imaged at ×100 using a Leica DM IRB microscope 
equipped with a high-resolution charge-coupled-device (CCD) camera (Orca-ER; Hamamatsu) 
and Openlab 5.5.1 software (Improvision).  
In vitro assays: parasite replication and differentiation.Intracellular T. gondii replication was 
assessed as previously described (19) by inoculating confluent HFF monolayers in six-well 
plates with 2 × 105 freshly purified tachyzoites. The monolayers were washed to remove 
extracellular parasites at 4 h, and replication was assessed at 12, 24, 30, and 36 h by fixation in 
3.7% paraformaldehyde, staining with Giemsa stain, and scoring the number of intracellular 
parasites in 100 parasitophorous vacuoles selected at random. Each time point represents 
triplicate assays from two independent experiments; statistical analysis was based on the two-
tailed Student's t test.  
Parasite differentiation (17) was induced by inoculation of HFF monolayers in six-well plates, 
switching to minimal essential medium (MEM) containing 1 g/liter NaHCO3 plus 50 mM Tricine 
(pH 8.1) at 4 h postinfection, and incubation at 37°C in 0.03% CO2, replacing the medium every 
6 to 8 h to maintain a constant alkaline pH. At 48 h, the cultures were fixed in 3.7% 
paraformaldehyde, permeabilized in 0.2% Triton X-100, blocked with 10% fetal bovine serum, 
and stained with 1:100 tetramethyl rhodamine isocyanate (TRITC)-conjugated Dolichos biflorus 
lectin (Sigma). One hundred randomly selected parasitophorous vacuoles were scored for a 
homogeneous cyst wall (average of three independent experiments).  
Quantification of the parasite burden in vivo. Female 6- to 8-week-old BALB/c mice were 
infected by intraperitoneal injection of 103 parasite tachyzoites (RH wild type, ΔTgPI1 mutant, or 
RHΔTgPI1 complemented with TgPI1α or TgPI1β). After sacrifice at 7 days postinfection, DNA 
was extracted from the liver, spleen, and brain (High Pure PCR Kit; Roche), and 100 ng of each 
sample was analyzed by quantitative PCR (25) using primers 5′-
TCTTTAAAGCGTTCGTGGTC-3′ (forward) and 5′-GGAACTGCATCCGTTCATGAG-3′ 
(reverse) to determine the abundance of the multicopy T. gondii B1 gene (25) relative to a mouse 
β-actin control (forward, 5′-TCACCCACACTGTGCCCATCTACGA-3′; reverse, 5′-
CAGCGGAACCGCTCATTGCCAATGG-3′). After 10 min of denaturation at 95°C, thermal 
cycling was carried out using 40 cycles of 1 min annealing/extension at 60°C, alternating with 15 
s of denaturation at 95°C (Applied Biosystems 7500) and SYBR green detection. The 2−ΔΔCT 
method was used to calculate the relative parasite burdens in different tissues; analysis of serial 
dilutions of DNA from infected livers demonstrated similar amplification efficiencies for the 
TgB1 target and mouse β-actin over a wide range of DNA concentrations.  
Nucleotide sequence accession numbers. Updated TgPI1 sequence information is available at 
ToxoDB.org (TgME49_008450) and in GenBank (accession numbers HM536610 [TgPI1α], 
AF121778 [TgPI1β], and HM536941 [genomic]).  
Results and Discussion 
Alternative splicing of a 72-nucleotide exon produced two TgPI1 isoforms.Immunoblotting 
demonstrated two TgPI1 isoforms in each of the three dominant lineages of T. gondii (Fig. 1A), 
as previously described for RH strain parasites (40, 44). Expression levels of the smaller isoform 
(designated TgPI1β) were comparable in all strains tested, but the larger isoform (TgPI1α) was 
reproducibly less abundant than TgPI1β in strain RH, more abundant than TgPI1β in the Pru 
strain, and comparable to TgPI1β in VEG strain parasites. 
To determine whether these two isoforms arise by posttranslational modification, extracellular T. 
gondii strain RH tachyzoites were labeled with 35S-labeled amino acids for 15 min, and TgPI1 
was immunoprecipitated after 0 to 60 min of incubation in unlabeled medium. Both isoforms 
were observed at all time points (Fig. 1B), indicating that TgPI1α and -β do not exhibit a 
precursor-product relationship, i.e., they are probably not attributable to proteolytic cleavage or 
other posttranslational modifications. Also, the altered migration is not due to differential N-
linked glycosylation occurring cotranslationally in the endoplasmic reticulum, as the TgPI1 
deduced sequence is devoid of a consensus motif (NXS/T) for N-glycan addition.  
To further investigate the relationship between TgPI1α and -β, the isoforms were immunoaffinity 
purified from the supernatant of a heavily infected HFF monolayer shortly after parasite egress 
(when TgPI1 is released from the disrupted vacuoles), and bands  
obtained by gel electrophoresis were subjected to MALDI-TOF mass spectrometry (Fig. 1C). 
Intact protein masses were measured at 34.3 kDa for TgPI1α and 31.5 kDa for TgPI1β, and the 
molecular mass difference between the isoforms was estimated to be 2,775 ± 31 Da. A peptide 
mass fingerprint generated by tryptic digestion prior to MALDI-TOF revealed very similar 
spectra for TgPI1α and TgPI1β (Fig. 1D), differing only in the presence of a unique m/z peak at 
1,652.7. This peak corresponds to a 15-amino-acid tryptic peptide (TQSSHQHDDAENGAR) 
that is unique to TgPI1α, suggesting that TgPI1α has a distinct genetically encoded segment.  
To determine if the distinct segment is due to differential RNA splicing, we performed RT-PCR 
of total RNA from RH strain parasites using forward and reverse primers encompassing the full-
length TgPI1 coding sequence. This analysis yielded distinct transcripts of 887 nucleotides (nt) 
and 815 nt; the same bands were obtained by RT-PCR from an RH strain tachyzoite cDNA 
library, while a single band of 2,973 nt was obtained from genomic DNA (Fig. 1E). The relative 
abundances of the two TgPI1 transcripts correlate with the relative abundances of the two protein 
isoforms in RH strain parasites (Fig. 1A, lane 1). Sequencing of the cloned products revealed that 
the larger species contains a 75-nt insertion predicted to encode 25 amino acids, including the 
extra peptide identified by mass spectrometry. This 25-amino-acid insert has a predicted mass of 
2,752 Da, which is within the measurement range of the mass difference between TgPI1α and 
TgPI1β (2,775 ± 31 Da). Comparison with the TgME49_008450 genomic locus (ToxoDB.org) 
identified the extra sequence as a distinct exon, defining alternatively spliced mRNAs of 8 versus 
9 exons (Fig. 1F); several expressed sequence tags (ESTs) validate each of these transcripts and 
confirm the alternative splicing of TgPI1. All predicted TgPI1 introns begin with GT and end 
with AG, in agreement with the consensus for other eukaryotes (including T. gondii), and 
sequence upstream of the first ATG corresponds to the consensus for translational initiation in T. 
gondii (AAAATG). The first 24 amino acids (most of the first exon) are predicted to comprise a 
secretory signal sequence. Exons 2, 4, 7, and 9 each encode a Kazal domain (asterisks in Fig. 
1F), while exons 1, 3, 5, 6, and 8 encode linkers between the Kazal domains (44); the 
alternatively spliced exon expands the linker between the third and fourth Kazal domains in 
TgPI1α. This modular structure is consistent with the repeated duplications typical of 
multidomain Kazal inhibitor evolution (29). The identification of alternative splicing of the 
TgPI1 gene adds to the growing list of examples of transcript (and protein) diversity generated 
by splicing in T. gondii (14, 16, 30, 53). 
Targeted deletion and complementation of the TgPI1 locus. To investigate the function of 
TgPI1, the genomic locus was deleted by homologous replacement using HXGPRT as a positive 
selectable marker in the RHΔHXGPRT background (16). Figure 2A displays the TgPI1 genomic 
locus and the targeting construct used to generate ΔTgPI1 knockout parasites. Transfected 
parasites were inoculated into HFF in six wells of a 24-well plate, selected in mycophenolic acid, 
and screened by PCR upon host cell lysis (∼5 to 7 days posttransfection) to identify wells 
containing candidate knockouts. Individual parasites from two positive wells were cloned by 
limiting dilution in 96-well plates and rescreened by PCR (Fig. 2B) to identify clones lacking the 
TgPI1 gene (Fig. 2A, P1-P2) in which the selectable marker had integrated at the endogenous 
TgPI1 locus (P3-P4 and P3-P5). Gene replacement was confirmed by Southern blotting: a probe 
amplified from genomic DNA showed complete loss of TgPI1 coding sequence (Fig. 2C, left, 
compare lane 1 with lanes 2 and 3), and a flanking sequence probe demonstrated the expected 
800-nt decrease in size from the 12.3-kb EcoRI fragment encompassing TgPI1 (Fig. 2C, right, 
lane 1 versus lanes 2 and 3). 
For genetic complementation, TgPI1 knockout (ΔTgPI1) parasites were transfected with 
plasmids engineered to express cDNA encoding TgPI1α or TgPI1β fused to GST, to facilitate 
future pull-down studies, flanked by a β-tubulin promoter and a dihydrofolate reductase-
thymidylate synthase (DHFR-TS) 3′ untranslated region. A chloramphenicol acetyltransferase 
(CAT) selectable marker was incorporated into the complementation plasmid, and Southern 
blotting of genomic DNA from clonal parasite transfectants revealed the expected 5.2-kb EcoRI 
fragment containing the TgPI1 transgene; additional bands corresponded to integration events 
fragmenting the TgPI1 transgene (Fig. 2C, left, lanes 4 and 5). Western blotting using rabbit anti-
TgPI1 (Fig. 2D) or anti-GST (not shown) demonstrated loss of TgPI1 in ΔTgPI1 parasites and 
expression of a single TgPI1-GST protein of the expected size in TgPI1α or TgPI1β transgenic 
parasite lysates (smaller bands may be attributable to proteolytic cleavage).  
Targeted deletion of a gene family member in T. gondii can lead to upregulation of another 
member of the gene family (46). To determine whether deletion of TgPI1 resulted in 
compensatory upregulation of other T. gondii genes, including those encoding other serine 
protease inhibitors, we performed genome-wide expression profiling using a custom T. gondii 
Affymetrix microarray (Toxodb.org) (Fig. 2E). Interpro motif searches identified eight putative 
protease inhibitors in the T. gondii genome: six Kazal-type inhibitors (TgME49_008450 [TgPI1], 
TgME49_008430 [TgPI2], TgME49_083470, TgME49_059890, TgME49_024080, and 
TgME49_066610) and two serpins (TgME49_017430 and TgME49_046130). Only four of them 
exhibited steady-state transcript levels above background (TgPI1, TgPI2, and the two serpins). 
As expected, TgPI1 transcripts were reduced to background levels (>200-fold decrease) in the 
ΔTgPI1 mutants. Steady-state transcript levels for TgPI2 were ∼10-fold lower than for TgPI1 in 
both control parasites and the ΔTgPI1 knockout. This finding confirms earlier studies showing 
low but detectable expression of TgPI2 protein in tachyzoites (39), and it demonstrates a lack of 
compensation by TgPI2 in the ΔTgPI1 knockout. Similarly, no compensatory expression or other 
changes were observed in other protease inhibitor genes. These observations were confirmed by 
quantitative PCR (not shown).  
TgPI1α and TgPI1β are secreted into the parasitophorous vacuole and are also transferred 
to the host cell cytoplasm. Indirect immunofluorescence using rabbit antisera to recombinant 
TgPI1 showed expression of TgPI1 in parental RHΔHXGPRT parasites (Fig. 3A), loss of 
expression in ΔTgPI1 (Fig. 3B), and restoration in both ΔTgPI1 plus PI1α-GST and ΔTgPI1 plus 
PI1β-GST transgenics (Fig. 3C and D). TgPI1 is secreted via dense granules into the 
parasitophorous vacuole (45) (Fig. 3A), and expression of TgPI1α or TgPI1β in ΔTgPI1 
knockout mutants demonstrated that both isoforms were also secreted into the parasitophorous 
vacuole (Fig. 3C and D). Interestingly, TgPI1 was also observed in the cytoplasm of a subset 
(57% ± 5% in three independent replicates) of infected host cells, along with another dense-
granule protein, GRA1 (Fig. 3E). In contrast, a P30-OVA transgene (43) expressed in the same 
cells was not seen in the host cell cytoplasm despite being abundantly present in the 
parasitophorous vacuole (Fig. 3F). P30-OVA, which consists of the P30 (SAG1) signal sequence 
fused to the model antigen ovalbumin, serves as a default secretory marker lacking specific 
targeting signals. Moreover, TgPI1 localization to the host cytoplasm was observed in a majority 
of infected host cells, including those containing small, as well as large, parasitophorous 
vacuoles, although fluorescence is usually stronger in the latter, presumably due to the presence 
of more parasites secreting TgPI1. The fact that TgPI1 and GRA1 were seen in the cytoplasm of 
host cells containing a range of parasitophorous vacuoles suggests that cytoplasmic transfer was 
not a result of vacuolar permeabilization resulting from imminent parasite egress. For further 
validation, we transfected ΔTgPI1 parasites with plasmids encoding TgPI1α fused to monomeric 
red fluorescent protein (mRFP) or TgPI1β fused to yellow fluorescent protein (YFP). Both of 
these TgPI1–fluorescent-protein fusions were observed in the cytoplasm of live infected HFF 
(Fig. 3G and H), ruling out the possibility that transfer of TgPI1 to the host cytoplasm occurred 
during fixation. These findings suggest that TgPI1 has access to potential targets in the host 
cytoplasm, thus opening the possibility that TgPI1 suppresses host proteases during intracellular 
growth. 
ΔTgPI1 tachyzoites exhibit normal replication but enhanced differentiation in vitro. To determine if 
TgPI1 influences parasite replication, confluent HFF monolayers were inoculated with an equivalent 
number of wild-type RH strain tachyzoites, RHΔHXGPRT parasites, ΔTgPI1 knockouts, or clonal 
parasite lines complemented with TgPI1α-GST or TgPI1β-GST. ΔHXGPRT parasites display a slight 
growth defect (Fig. 4A) (a doubling time of 9.2 ± 0.9 h for RHΔHXGPRT versus 7.1 ± 0.6 h for wild-type 
RH), as previously described (9). However, ΔTgPI1 knockout parasites, which express HXGPRT, 
displayed a doubling time (∼7.8 ± 0.4 h) that was indistinguishable from that of wild-type RH. Strains 
expressing TgPI1α and TgPI1β also exhibited doubling times similar to that of the wild type (∼6.7 and 
7.7 h, respectively). Thus, TgPI1 expression appears to have no significant impact on T. gondii tachyzoite 
replication in vitro. Since RHΔHXGPRT has different growth properties due to the lack of HXGPRT 
expression, the wild-type RH strain is used here as the reference strain. 
T. gondii strain RH does not form mature bradyzoite cysts in mice but can be induced to 
differentiate in vitro under stress conditions, such as exposure to alkaline pH (4, 5, 17, 18, 52, 54, 
57). Bradyzoite-specific antigens are detected as early as 12 to 24 h postinduction (P. H. Davis, 
unpublished data), and cyst wall development can be visualized by staining with D. biflorus 
lectin (6). To test if TgPI1 plays a role in stage differentiation, confluent monolayers of HFF 
were infected with wild-type RH, the ΔHXGPRT or ΔTgPI1 knockout mutant, and 
complemented parasite lines and assayed for differentiation after 48 h of incubation at pH 8.1 
(Fig. 4B). ΔTgPI1 knockout parasites showed a 64-fold upregulation of the bradyzoite-specific 
enolase isozyme ENO1 (Fig. 4B) (27) relative to wild-type T. gondii. Knockout parasites also 
showed a similar hyperinduction of other bradyzoite stage-specific markers, including 
P18/SAG4.2, BAG1, and LDH2 (upregulated 13-, 25-, and 30-fold, respectively).  
Low levels of Dolichos staining were observed in alkali-treated T. gondii strain RH cultures (Fig. 
4C, left), perhaps associated with the intravacuolar membrane network (34), but only ∼8% of 
these vacuoles showed evidence of bradyzoite cyst differentiation, including (i) high levels of 
Dolichos lectin staining on the vacuolar surface, (ii) reduced replication (2 to 8 parasites within 
the vacuole versus 16 to 32 in tachyzoite-containing vacuoles), (iii) rounded parasite morphology 
lacking the “rosette” organization typical of tachyzoites, and (iv) rounded, cyst-like vacuoles 
(Fig. 4C). In contrast, 74% of vacuoles containing ΔTgPI1 knockouts were strongly Dolichos 
positive, and complementation with either TgPI1α or TgPI1β substantially reversed the 
differentiation phenotype (Fig. 4B). Thus, deletion of TgPI1 enhances bradyzoite differentiation 
of RH strain parasites in vitro. While other T. gondii mutants are also prone to enhanced 
bradyzoite differentiation (cf. the ΔHXGPRT mutant in Fig. 4B), the ΔTgPI1 effect is 
particularly profound. It is possible that TgPI1 inhibits proteases involved in bradyzoite cyst 
formation, as the cyst wall contains chitin (6) and there is ample precedent for proteolytic 
regulation of chitin in other systems (7, 13, 37).  
Deletion of TgPI1 increases the parasite tissue burden in infected mice. To assess the importance of 
TgPI1 in vivo, BALB/c mice were inoculated with freshly harvested tachyzoites by intraperitoneal 
injection, and the liver, spleen, and brain were harvested from euthanized animals during the acute phase 
of infection 7 days postinoculation. The parasite tissue burden was measured by quantitative PCR. 
Infection with RH strain parasites develops rapidly and is typically fatal on approximately day 8 
postinoculation, which is prior to the initiation of the chronic phase of infection (days 10 to 12 for 
cystogenic strains [15]). As shown in Fig. 4D, ΔTgPI1 tachyzoites reproducibly displayed significantly 
higher parasite burdens than the RH strain in all tissues (three independent experiments). 
Complementation with either TgPI1α or TgPI1β reduced the parasite burden to the level observed in wild-
type controls in the spleen. A similar trend was seen in the liver, although ΔTgPI1β did not fully reverse 
the elevated parasite burden phenotype. Neither TgPI1α nor TgPI1β restored the normal parasite burden 
in the brain, which is low and highly variable, thus possibly explaining the apparent lack of 
complementation. Alternatively, it is possible that TgPI1α and TgPI1β each target different proteases in 
the brain, and therefore, complementation with both isoforms would be necessary to restore normal 
infection levels. 
Most other dense-granule protein mutants that have been characterized to date exhibit either no phenotype 
(GRA5) (27) or reduced virulence (GRA2, GRA3, and GRA6) (12, 35, 36). In contrast, deletion of TgPI1 
appears to enhance the parasite burden during acute tachyzoite infection of mice. This phenotype is 
reminiscent of a recently reported type II strain GRA15 knockout mutant, which replicated to greater 
levels in mice than wild-type parasites (48). GRA15 is associated with the PV and appears to have access 
to the cytoplasm of infected host cells, where it activates nuclear translocation of NF-κB in a parasite 
strain-dependent manner, resulting in upregulation of several genes, including the proinflammatory 
cytokine interleukin 12 (IL-12). Rapid production of IL-12 during early infection with type II parasites 
induces gamma interferon (IFN-γ), which suppresses parasite growth (38). Conversely, deletion of 
GRA15 delays production of IL-12 and IFN-γ, thus permitting rapid growth and a higher parasite burden 
in vivo. While TgPI1 ablation also leads to a higher parasite burden in vivo, precisely how TgPI1 affects 
parasite growth in mice remains to be determined. Although higher levels of TgPI1 expression, especially 
TgPI1α, in the Pru strain correlates with the slower growth and reduced virulence of this type II strain, 
strain-specific virulence genes have not been mapped to chromosome Ib, where TgPI1 is encoded. Future 
studies focused on the identification of proteases targeted by TgPI1 during infection should provide 
further insight into how TgPI1 influences T. gondii differentiation and growth in vivo. 
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Figures 
 
Fig 1  
TgPI1α and TgPI1β are mRNA splice variants. (A) Western blotting with anti-TgPI1 revealed 
two isoforms (TgPI1α and TgPI1β) in T. gondii strains RH (type I), Pru (type II), and VEG (type 
III). Each lane contained 106 parasite equivalents. (B) Pulse-chase labeling of intracellular RH 
strain tachyzoites with 35S-labeled amino acids showed no evidence of posttranslational 
modification. (C) MALDI-TOF analysis of the two intact isoforms revealed an exact molecular 
mass difference of 2,775 Da (the average of three independent replicates). (D) MALDI-TOF 
analysis of tryptic fragments revealed a peak at m/z 1,652.7 specific to TgPI1α (arrow). (E) RT-
PCR showed reverse transcriptase (RT)-dependent amplification of 887- and 815-nt bands in 
samples containing total tachyzoite RNA (lane 1) or a cDNA library (lane 4); amplification from 
genomic DNA yielded a 2,973-nt band (lane 5). (F) Schematic representation of the two 
alternatively spliced variants of TgPI1. The boxes represent exons (open, untranslated; filled, 
coding; gray, alternatively spliced exon 6). The white stars indicate predicted Kazal domains.  
 
 
 Fig 2  
Targeted deletion of the TgPI1 locus. (A) (Top) Scale diagram of the 12.3-kb EcoR I fragment 
spanning the TgPI1 genomic locus. The boxes represent all nine TgPI1 exons (open, 
untranslated; filled, coding; gray, alternatively spliced exon in TgPI1α). (Bottom) 
dhfrHXGPRTdhfr targeting construct used for gene disruption. The shaded parallelograms 
denote identity to sequences flanking TgPI1 (2.5 kb upstream and 3.6 kb downstream). 
Arrowheads, primers for PCR screening; bars, probes for Southern hybridization. (B) PCR of the 
TgPI1 locus in RHΔHXGPRT parental parasites and one (of several) ΔTgPI1 mutant clones. The 
TgPI1 locus is present in parental parasites, but not the mutant (P1-P2) or the targeting construct 
integrated at the genomic locus (P3-P5 and P3-P4). Panel A shows the primer positions. (C) 
Southern blot illustrating deletion of the genomic TgPI1 locus in two ΔTgPI1 clones and 
integration of TgPI1α or TgPI1β transgenes at heterologous sites in complemented lines (panel A 
shows the probes). (D) Western blot with rabbit anti-TgPI1 illustrating expression of both 
TgPI1α and TgPI1β isoforms in parental parasites, loss in ΔTgPI1 mutants, and expression of 
TgPI1α-GST or TgPI1β-GST fusion proteins in parasites expressing complementation constructs. 
(E) Microarray analysis of steady-state transcript abundance (log2 values) for TgPI1 and other 
protease inhibitor genes in parental RHΔHXGPRT and ΔTgPI1 parasites. The gray shading 
indicates background expression levels.  
  
  
Fig 3  
TgPI1α and TgPI1β are secreted into the parasitophorous vacuole and the host cell cytoplasm. (A 
to D) Immunofluorescence with anti-TgPI1 demonstrates staining of the parasitophorous vacuole 
in parental parasites, no staining in ΔTgPI1 mutants, and restoration in knockouts complemented 
with either TgPI1α-GST or TgPI1β-GST. The arrows indicate vacuoles containing parasites 
expressing TgPI1. (E and F) Colocalization of TgPI1 and GRA1, but not P30-OVA, in the 
cytoplasm of host cells infected with parasites expressing a P30-OVA transgene. (G and H) 
Identification of TgPI1α and TgPI1β in the host cell cytoplasm using fluorescent protein 
reporters (in live cell cultures). The closed arrowheads indicate staining of the parasitophorous 
vacuole and cytoplasm of host cells. The open arrowheads show vacuoles with no evidence of 
TgPI1 staining in the cytoplasm of host cells.  
 
  
  
Fig 4  
Phenotypic effects of ΔTgPI1 in vitro and in vivo. (A) ΔTgPI1 mutants are identical to wild-type 
parasites with respect to proliferation in vitro, as assessed by scoring parasite replication at 
various times postinfection (the average log2[parasite number] for 100 intracellular vacuoles, in 
triplicate). Doubling times were ∼6.7 to 7.8 h for wild-type RH, ΔTgPI1 knockout mutants, and 
ΔTgPI1 plus PI1α- and ΔTgPI1 plus TgPI1β-complemented lines, in contrast to the slightly 
crippled replication rate of RHΔHXGPRT (9.2 ± 0.9 h). The error bars indicate standard 
deviations (SD). (B) Enhanced in vitro differentiation of ΔTgPI1. Treatment for 48 h at pH 8.1 
induced expression of the bradyzoite differentiation marker ENO1 (measured by quantitative 
PCR) and surface staining with D. biflorus lectin. Differentiation of ΔTgPI1 was more extensive 
than that of ΔHXGPRT and much more than was observed in wild-type parasites. Partial 
complementation was observed in both ΔTgPI1 plus PI1α and ΔTgPI1 plus PI1β; ND, not 
determined. Ave., average; SE, standard error. (C) Morphology of alkaline-treated parasite 
cultures stained with fluorescent Dolichos lectin. Weak intravacuolar staining was observed for 
∼70% of wild-type parasites (left), while ∼8% displayed strong Dolichos staining of the 
vacuolar surface and rounded bradyzoite cyst-like morphology (the remaining vacuoles were 
unstained). Approximately 70% of ΔTgPI1 vacuoles displayed bradyzoite morphology, even 
when extensive replication was observed (far right). (D) Enhanced virulence of ΔTgPI1 in vivo. 
Female BALB/c mice inoculated with 103 tachyzoites showed higher tissue burdens of ΔTgPI1 
than of the wild-type in the liver, spleen, and brain at day 7 postinfection. Full or partial 
complementation was observed for both ΔTgPI1 plus PI1α and ΔTgPI1 plus TgPI1β in the liver 
and spleen, but not the brain (the bars show means ± SD for 2 or 3 experiments involving 2 to 5 
mice per sample). The asterisks indicate a P value of ≤0.05 relative to RH (wild type). See the 
text for further discussion.  
 
